Humana Inc. vs Eli Lilly & Co.
HUM vs LLY — side-by-side comparison from reported financials. HUM leads 5, LLY leads 7 of 12 comparable metrics.
Humana Inc.
HUM · Healthcare
$438.49+13.27%Mixed
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | HUM | LLY |
|---|---|---|
| Price | $438.49 | $1 177.20 |
| Market cap | $52.6B | $1.05T |
| Revenue (TTM) | $146B | $79.7B |
| Revenue growth | +11.8% | +31.7% |
| Net margin | 0.9% | 33.5% |
| Free cash flow | $1.95B | $18.2B |
| Net cash (debt) | $7.53B | ($35.2B) |
| 1-year price return | +50.9% | +37.6% |
| P/E | 40.5 | 41.6 |
| P/E vs own history (cheap-side %) | 0% | 88% |
| Dividend yield | 0.83% | 0.52% |
| Return on equity | 7% | 93% |
| Altman Z-score | 2.34 | 7.10 |
| CV checks passed | 10 of 11 | 11 of 11 |
| Employees | 67,060 | 50,000 |
Full résumé-style profiles: HUM CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.